Five Prime Therapeutics, Inc. Net Income
Five Prime Therapeutics, Inc. reported Net Income of -$20.85 million for the 3-month period ending 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2021-03-22
- Five Prime Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2020-12-31 was -$20.85M.
- Five Prime Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2020-09-30 was -$26.42M.
- Five Prime Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2020-06-30 was -$16.94M.
- Five Prime Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2020-03-31 was -$20.12M.
- Five Prime Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2020 was -$84.33M.
- Five Prime Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2019 was -$137.20M.
- Five Prime Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2018 was -$140.45M.
- Five Prime Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2017 was -$150.22M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$20.85M 10-K · filed 2021-03-22 | -$47.27M derived: sum of 2 quarters · filed 2021-03-22 | -$64.21M derived: sum of 3 quarters · filed 2021-03-22 | -$84.33M 10-K · filed 2021-03-22 |
| 2020-09-30 | -$26.42M 10-K · filed 2021-03-22 | -$43.36M derived: sum of 2 quarters · filed 2021-03-22 | -$63.48M 10-Q · filed 2020-11-03 | -$94.83M derived: sum of 4 quarters · filed 2021-03-22 |
| 2020-06-30 | -$16.94M 10-K · filed 2021-03-22 | -$37.05M 10-Q · filed 2020-08-06 | -$68.41M derived: sum of 3 quarters · filed 2021-03-22 | -$104.48M derived: sum of 4 quarters · filed 2021-03-22 |
| 2020-03-31 | -$20.12M 10-K · filed 2021-03-22 | -$51.47M derived: sum of 2 quarters · filed 2021-03-22 | -$87.54M derived: sum of 3 quarters · filed 2021-03-22 | -$121.93M derived: sum of 4 quarters · filed 2021-03-22 |
| 2019-12-31 | -$31.36M 10-K · filed 2021-03-22 | -$67.43M derived: sum of 2 quarters · filed 2021-03-22 | -$101.82M derived: sum of 3 quarters · filed 2021-03-22 | -$137.20M 10-K · filed 2021-03-22 |
| 2019-09-30 | -$36.07M 10-K · filed 2021-03-22 | -$70.46M derived: sum of 2 quarters · filed 2021-03-22 | -$105.84M 10-Q · filed 2020-11-03 | -$144.60M derived: sum of 4 quarters · filed 2021-03-22 |
| 2019-06-30 | -$34.39M 10-K · filed 2021-03-22 | -$69.78M 10-Q · filed 2020-08-06 | -$108.53M derived: sum of 3 quarters · filed 2021-03-22 | -$155.77M derived: sum of 4 quarters · filed 2021-03-22 |
| 2019-03-31 | -$35.38M 10-K · filed 2021-03-22 | -$74.14M derived: sum of 2 quarters · filed 2021-03-22 | -$121.38M derived: sum of 3 quarters · filed 2021-03-22 | -$155.44M derived: sum of 4 quarters · filed 2021-03-22 |
| 2018-12-31 | -$38.75M 10-K · filed 2020-02-27 | -$86.00M derived: sum of 2 quarters · filed 2020-02-27 | -$120.06M derived: sum of 3 quarters · filed 2020-02-27 | -$140.45M 10-K · filed 2021-03-22 |
| 2018-09-30 | -$47.24M 10-K · filed 2020-02-27 | -$81.30M derived: sum of 2 quarters · filed 2020-02-27 | -$101.69M 10-Q · filed 2019-11-06 | -$130.91M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$34.06M 10-K · filed 2020-02-27 | -$54.45M 10-Q · filed 2019-08-08 | -$83.66M derived: sum of 3 quarters · filed 2020-02-27 | -$126.94M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$20.39M 10-K · filed 2020-02-27 | -$49.60M derived: sum of 2 quarters · filed 2020-02-27 | -$92.88M derived: sum of 3 quarters · filed 2020-02-27 | -$137.17M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$29.21M 10-K · filed 2019-02-26 | -$72.49M derived: sum of 2 quarters · filed 2019-02-26 | -$116.78M derived: sum of 3 quarters · filed 2019-02-26 | -$150.22M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$43.28M 10-K · filed 2019-02-26 | -$87.57M derived: sum of 2 quarters · filed 2019-02-26 | -$121.01M 10-Q · filed 2018-11-06 | -$141.12M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | -$44.29M 10-K · filed 2019-02-26 | -$77.73M 10-Q · filed 2018-08-08 | -$97.83M derived: sum of 3 quarters · filed 2019-02-26 | -$117.25M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | -$33.44M 10-K · filed 2019-02-26 | -$53.55M derived: sum of 2 quarters · filed 2019-02-26 | -$72.96M derived: sum of 3 quarters · filed 2019-02-26 | -$86.10M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | -$20.11M 10-K · filed 2018-02-27 | -$39.52M derived: sum of 2 quarters · filed 2018-02-27 | -$52.66M derived: sum of 3 quarters · filed 2018-02-27 | -$65.70M 10-K · filed 2019-02-26 |
| 2016-09-30 | -$19.41M 10-K · filed 2018-02-27 | -$32.55M derived: sum of 2 quarters · filed 2018-02-27 | -$45.59M 10-Q · filed 2017-11-06 | $250.54M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$13.14M 10-K · filed 2018-02-27 | -$26.18M 10-Q · filed 2017-08-08 | $269.95M derived: sum of 3 quarters · filed 2018-02-27 | $245.98M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$13.04M 10-K · filed 2018-02-27 | $283.09M derived: sum of 2 quarters · filed 2018-02-27 | $259.12M derived: sum of 3 quarters · filed 2018-02-27 | $247.64M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $296.13M 10-K · filed 2017-02-24 | $272.16M derived: sum of 2 quarters · filed 2017-02-24 | $260.68M derived: sum of 3 quarters · filed 2017-02-24 | $249.65M 10-K · filed 2018-02-27 |
| 2015-09-30 | -$23.97M 10-K · filed 2017-02-24 | -$35.45M derived: sum of 2 quarters · filed 2017-02-24 | -$46.48M 10-Q · filed 2016-11-04 | -$58.31M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | -$11.47M 10-K · filed 2017-02-24 | -$22.51M 10-Q · filed 2016-08-05 | -$34.34M derived: sum of 3 quarters · filed 2017-02-24 | -$41.42M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | -$11.04M 10-K · filed 2017-02-24 | -$22.86M derived: sum of 2 quarters · filed 2017-02-24 | -$29.95M derived: sum of 3 quarters · filed 2017-02-24 | -$39.82M derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | -$11.83M 10-K · filed 2016-03-11 | -$18.91M derived: sum of 2 quarters · filed 2016-03-11 | -$28.78M derived: sum of 3 quarters · filed 2016-03-11 | -$37.42M 10-K · filed 2017-02-24 |
| 2014-09-30 | -$7.09M 10-K · filed 2016-03-11 | -$16.95M derived: sum of 2 quarters · filed 2016-03-11 | -$25.60M 10-Q · filed 2015-11-05 | -$32.91M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | -$9.87M 10-K · filed 2016-03-11 | -$18.51M 10-Q · filed 2015-08-07 | -$25.83M derived: sum of 3 quarters · filed 2016-03-11 | -$33.06M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | -$8.64M 10-K · filed 2016-03-11 | -$15.96M derived: sum of 2 quarters · filed 2016-03-11 | -$23.20M derived: sum of 3 quarters · filed 2016-03-11 | -$30.47M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | -$7.32M 10-K · filed 2015-03-18 | -$14.55M derived: sum of 2 quarters · filed 2015-03-18 | -$21.82M derived: sum of 3 quarters · filed 2015-03-18 | -$28.87M 10-K · filed 2016-03-11 |
| 2013-09-30 | -$7.23M 10-K · filed 2015-03-18 | -$14.51M derived: sum of 2 quarters · filed 2015-03-18 | -$21.55M 10-Q · filed 2014-11-12 | -$28.37M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-06-30 | -$7.27M 10-K · filed 2015-03-18 | -$14.32M 10-Q · filed 2014-08-07 | -$21.13M derived: sum of 3 quarters · filed 2015-03-18 | -$26.99M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-03-31 | -$7.05M 10-K · filed 2015-03-18 | -$13.86M derived: sum of 2 quarters · filed 2015-03-18 | -$19.72M derived: sum of 3 quarters · filed 2015-03-18 | -$26.56M derived: sum of 4 quarters · filed 2015-03-18 |
| 2012-12-31 | -$6.81M 10-K · filed 2014-03-26 | -$12.67M derived: sum of 2 quarters · filed 2014-03-26 | -$19.51M derived: sum of 3 quarters · filed 2014-03-26 | -$27.59M 10-K · filed 2015-03-18 |
| 2012-09-30 | -$5.86M 10-K · filed 2014-03-26 | -$12.70M derived: sum of 2 quarters · filed 2014-03-26 | -$20.78M 10-Q · filed 2013-11-13 | |
| 2012-06-30 | -$6.84M 10-K · filed 2014-03-26 | -$14.92M derived: sum of 2 quarters · filed 2014-03-26 | ||
| 2012-03-31 | -$8.08M 10-K · filed 2014-03-26 | |||
| 2011-12-31 | $887.00K 10-K · filed 2014-03-26 |